Neuland Laboratories Ltd

Neuland Laboratories Ltd

11th Floor (5th Level), Phoenix IVY Building, Plot No. 573A-III, Road No. 82, Jubilee Hills, Hyderabad, 500033, Telangana, India

AboutNeuland Laboratories Ltd

Neuland Laboratories Limited was established in 1984 and today is a publicly listed company headquartered in Hyderabad, India. Neuland is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs.

We provide solutions across the full range of the pharmaceutical industry’s chemistry requirements, from the synthesis of library compounds to supplying NCEs and advanced intermediates at various stages in the clinical life-cycle, as well as commercial launch. Our strength is our expertise in manufacturing of APIs and advanced intermediates from our US FDA approved facilities. Our core competency lies in the application of strong process chemistry to manufacturing in a regulatory compliant environment, which is supported by a strong, well-qualified team of more than 1400 employees.

For over three decades, Neuland has been at the forefront of facilitating and accelerating drug development and cGMP manufacturing of APIs. The Company’s technical and scientific teams provide comprehensive solutions and services to the global pharmaceutical industry.

Key Points

  • Quality, EHS and compliance is at the heart of Neuland and across our facilities, with a track record of regulatory approvals (15 successful US FDA inspections)
  • Focusing on our API capabilities and providing services such as cost-effective synthesis, IP protection and regulatory expertise we strive to meet all of our customers’ API needs
  • Helping customers across the full spectrum of the product lifecycle, from preclinical all the way to generic, with over 75 APIs scaled up
  • A dedicated state-of-the-art 3,400m2 R&D centre, located near Hyderabad, with around 300 scientists
  • Two world-class manufacturing plants with 7 production blocks in Unit 1 and 6 production blocks in Unit 2, covering 2,800 to 4,500m2 of production area, and a mini-plant for scaling up of new products
  • Total reactor volume of around 860+ KL and capable of handling a broad range of reactions and wide choice of process parameters